lobbying_activities: 2507610

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2507610	c571429c-ac0f-4c07-9da4-139b34efe08f	Q3	PARRY, ROMANI, DECONCINI & SYMMS	30792	PLEXUS WORLDWIDE	2020	third_quarter	CHM	HR 5587, To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol contained substances.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office			0	0	2020-10-14T13:05:34.350000-04:00